AngioDynamics, Inc.ANGONASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year research & development expense growth
Latest
-16.79%
↓ 4271% below average
Average (9y)
0.40%
Historical baseline
Range
High:22.60%
Low:-16.79%
CAGR
+10.7%
Consistent expansion
| Period | Value |
|---|---|
| 2025 | -16.79% |
| 2024 | 5.45% |
| 2023 | -2.78% |
| 2022 | -15.53% |
| 2021 | 22.60% |
| 2020 | 0.84% |
| 2019 | 15.62% |
| 2018 | 0.75% |
| 2017 | 0.57% |
| 2016 | -6.70% |